Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongxia Gao

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Virchows Archiv : an International Journal of Pathology|February 16, 2026
Utility of RB1 immunohistochemistry for prognostic subtyping of pulmonary large cell neuroendocrine carcinomaMichael Minkley, Kashif Ravasia, Thi Nghiem, et al.
Histopathology|July 2, 2026
TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinomaMichael Minkley, Kashif Ravasia, Thi Nghiem, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 31, 2011
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sitesMartin Köbel, Dmitry Turbin, Steve E Kalloger, et al.
Cancers|November 27, 2021
Prognostic Significance of CSF-1R Expression in Early Invasive Breast CancerNazia Riaz, Samantha Burugu, Angela S Cheng, et al.
Breast Cancer Research : BCR|September 7, 2014
Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltrationShuzhen Liu, William D Foulkes, Samuel Leung, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basal-like and HER2-enriched breast cancerPhilip S Bernard, Bingshu E Chen, Dongxia Gao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline BenefitElahe Shenasa, Ye He, Zehui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical TrialTorsten O Nielsen, Maj-Brit Jensen, Samantha Burugu, et al.
NPJ Breast Cancer|September 10, 2021
Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancerKarama Asleh, Nazia Riaz, Angela S Cheng, et al.
Breast Cancer Research and Treatment|September 16, 2019
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Virchows Archiv : an International Journal of Pathology|February 16, 2026
Utility of RB1 immunohistochemistry for prognostic subtyping of pulmonary large cell neuroendocrine carcinomaMichael Minkley, Kashif Ravasia, Thi Nghiem, et al.
Histopathology|July 2, 2026
TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinomaMichael Minkley, Kashif Ravasia, Thi Nghiem, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 31, 2011
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sitesMartin Köbel, Dmitry Turbin, Steve E Kalloger, et al.
Cancers|November 27, 2021
Prognostic Significance of CSF-1R Expression in Early Invasive Breast CancerNazia Riaz, Samantha Burugu, Angela S Cheng, et al.
Breast Cancer Research : BCR|September 7, 2014
Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltrationShuzhen Liu, William D Foulkes, Samuel Leung, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basal-like and HER2-enriched breast cancerPhilip S Bernard, Bingshu E Chen, Dongxia Gao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline BenefitElahe Shenasa, Ye He, Zehui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical TrialTorsten O Nielsen, Maj-Brit Jensen, Samantha Burugu, et al.
NPJ Breast Cancer|September 10, 2021
Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancerKarama Asleh, Nazia Riaz, Angela S Cheng, et al.
Breast Cancer Research and Treatment|September 16, 2019
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
Pageof 6